XTL Biopharmaceuticals Ltd Financial Flexibility Index
XTL Biopharmaceuticals Ltd financial flexibility index. XTL Biopharmaceuticals Ltd (H2K2) has a Financial Flexibility Index of -0.50x as of December 2024. Free cash flow of €-1.56 Million (operating CF €-1.62 Million minus capex €54.00K) represents -1% of total liabilities (€3.12 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of XTL Biopharmaceuticals Ltd (2016–2024)
Financial flexibility index of XTL Biopharmaceuticals Ltd from 2016 to 2024. Historical Financial Flexibility Index trend for XTL Biopharmaceuticals Ltd across 9 annual periods. Check how high is XTL Biopharmaceuticals Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
XTL Biopharmaceuticals Ltd Financial Flexibility Index by Year (2016–2024)
XTL Biopharmaceuticals Ltd financial flexibility index by year from 2016 to 2024. Year-by-year free cash flow to debt coverage for XTL Biopharmaceuticals Ltd. For the full cash flow conversion analysis, see XTL Biopharmaceuticals Ltd cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.50x | €-1.56 Million | €-1.62 Million | €3.12 Million | ▲ +85.4% |
| 2023 | -3.43x | €-707.00K | €-707.00K | €206.00K | ▲ +28.8% |
| 2022 | -4.82x | €-901.00K | €-901.00K | €187.00K | ▼ -490.2% |
| 2021 | -0.82x | €-1.05 Million | €-1.05 Million | €1.28 Million | ▲ +75.6% |
| 2020 | -3.34x | €-849.00K | €-850.00K | €254.00K | ▲ +14.4% |
| 2019 | -3.91x | €-906.00K | €-908.00K | €232.00K | ▼ -21.4% |
| 2018 | -3.22x | €-814.00K | €-816.00K | €253.00K | ▼ -750.0% |
| 2017 | -0.38x | €-1.12 Million | €-1.12 Million | €2.97 Million | ▲ +92.5% |
| 2016 | -5.05x | €-1.67 Million | €-1.73 Million | €330.00K | — |